
TriAxia Health leverages AI and longitudinal clinical and genomic data to provide insights for rare disease discovery, development, and commercialization. Their platform aggregates and harmonizes clinical EHR data with DNA and RNA sequence data, offering AI-driven insights for researchers. TriAxia's products include Bioinformatics and Genomics, Clinical Trial Support, and Real World Evidence + Advanced Analytics, all aimed at improving outcomes for patients with rare diseases. They have aggregated data for over 80,000 rare pulmonary disease patients and collaborated with leading biopharmas.

TriAxia Health leverages AI and longitudinal clinical and genomic data to provide insights for rare disease discovery, development, and commercialization. Their platform aggregates and harmonizes clinical EHR data with DNA and RNA sequence data, offering AI-driven insights for researchers. TriAxia's products include Bioinformatics and Genomics, Clinical Trial Support, and Real World Evidence + Advanced Analytics, all aimed at improving outcomes for patients with rare diseases. They have aggregated data for over 80,000 rare pulmonary disease patients and collaborated with leading biopharmas.